Insider Transactions in Q2 2025 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 21
2025
|
G Bradley Cole Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,673
+28.31%
|
-
|
|
May 21
2025
|
Kim Caple Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,673
+27.86%
|
-
|
|
May 21
2025
|
Rodney Cotton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,673
+38.25%
|
-
|
|
May 21
2025
|
Daniel Bradbury Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,673
+50.0%
|
-
|
|
May 21
2025
|
Miles Harrison Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,673
+28.31%
|
-
|
|
May 21
2025
|
Tiffany Olson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,673
+25.08%
|
-
|
|
May 21
2025
|
Ellen Goldberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,673
+24.14%
|
-
|
|
Apr 21
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
4,408
-3.55%
|
$92,568
$21.52 P/Share
|
|
Apr 21
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,236
-1.63%
|
$25,956
$21.52 P/Share
|
|
Apr 09
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,647
-2.85%
|
$72,940
$20.22 P/Share
|
|
Apr 09
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,023
-1.33%
|
$20,460
$20.22 P/Share
|
|
Apr 08
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
761
-0.59%
|
$15,220
$20.03 P/Share
|
|
Apr 08
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
213
-0.28%
|
$4,260
$20.03 P/Share
|